ArticleClinicoEconomics and outcomes research : CEOR2022

A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.

Oluwadara Olatoke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.